Altered Gut Microbiota Composition Associated with Eczema in InfantsOriginal paper
What was studied?
This study examined whether the composition of the gut microbiota in infants differs between those with eczema and those without. Researchers used high-throughput sequencing of the V3-V4 hypervariable regions of the 16S rRNA gene to profile bacterial communities in fecal samples. The analysis identified 12,386 operational taxonomic units (OTUs) at 97% similarity and compared taxa abundance and composition between groups.
Who was studied?
The study was a case-control comparison of 50 infants with eczema (cases) and 51 healthy infants without eczema (controls). Fecal samples from these 101 infants were the source material for the 16S rRNA sequencing analysis. No further demographic details are given in the abstract.
What were the most important findings?
Gut microbiota differed between groups in taxa abundance, though not in overall taxonomic composition. Healthy infants showed enrichment of Bifidobacterium, Megasphaera, Haemophilus and Streptococcus. Infants with eczema showed enrichment of Escherichia/Shigella, Veillonella, Faecalibacterium, Lachnospiraceae incertae sedis and Clostridium XlVa, with Faecalibacterium prausnitzii and Ruminococcus gnavus, taxa associated with atopy or inflammation, significantly enriched in the eczema group. Higher abundance of Akkermansia muciniphila in eczematous infants was also noted and may relate to reduced intestinal barrier integrity.
What are the greatest implications of this study?
The findings support a link between altered gut bacterial abundance and eczema in infancy, pointing to specific genera and species as candidate markers of the atopic gut. The enrichment of Faecalibacterium prausnitzii alongside other inflammation-associated taxa in eczema cases suggests that microbiota composition changes may accompany, or contribute to, atopic disease processes rather than protect against them in this context. These results could inform future research into microbiota-targeted approaches for eczema risk assessment or intervention in infants.